Correlation Between Relay Therapeutics and Edgewise Therapeutics
Can any of the company-specific risk be diversified away by investing in both Relay Therapeutics and Edgewise Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Relay Therapeutics and Edgewise Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Relay Therapeutics and Edgewise Therapeutics, you can compare the effects of market volatilities on Relay Therapeutics and Edgewise Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Relay Therapeutics with a short position of Edgewise Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Relay Therapeutics and Edgewise Therapeutics.
Diversification Opportunities for Relay Therapeutics and Edgewise Therapeutics
-0.61 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Relay and Edgewise is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Relay Therapeutics and Edgewise Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edgewise Therapeutics and Relay Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Relay Therapeutics are associated (or correlated) with Edgewise Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edgewise Therapeutics has no effect on the direction of Relay Therapeutics i.e., Relay Therapeutics and Edgewise Therapeutics go up and down completely randomly.
Pair Corralation between Relay Therapeutics and Edgewise Therapeutics
Given the investment horizon of 90 days Relay Therapeutics is expected to under-perform the Edgewise Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Relay Therapeutics is 1.05 times less risky than Edgewise Therapeutics. The stock trades about -0.03 of its potential returns per unit of risk. The Edgewise Therapeutics is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 840.00 in Edgewise Therapeutics on August 29, 2024 and sell it today you would earn a total of 2,368 from holding Edgewise Therapeutics or generate 281.9% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Relay Therapeutics vs. Edgewise Therapeutics
Performance |
| Timeline |
| Relay Therapeutics |
| Edgewise Therapeutics |
Relay Therapeutics and Edgewise Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Relay Therapeutics and Edgewise Therapeutics
The main advantage of trading using opposite Relay Therapeutics and Edgewise Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Relay Therapeutics position performs unexpectedly, Edgewise Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edgewise Therapeutics will offset losses from the drop in Edgewise Therapeutics' long position.| Relay Therapeutics vs. Eliem Therapeutics | Relay Therapeutics vs. Scpharmaceuticals | Relay Therapeutics vs. Milestone Pharmaceuticals | Relay Therapeutics vs. Seres Therapeutics |
| Edgewise Therapeutics vs. Eliem Therapeutics | Edgewise Therapeutics vs. Scpharmaceuticals | Edgewise Therapeutics vs. Milestone Pharmaceuticals | Edgewise Therapeutics vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |